9960 Stock Overview
Kindstar Global (Beijing) Technology, Inc.
Kindstar Globalgene Technology, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||HK$1.78|
|52 Week High||HK$6.36|
|52 Week Low||HK$1.73|
|1 Month Change||-13.17%|
|3 Month Change||-17.97%|
|1 Year Change||-70.13%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-80.31%|
Recent News & Updates
Kindstar Globalgene Technology (HKG:9960) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Despite posting some strong earnings, the market for Kindstar Globalgene Technology, Inc.'s ( HKG:9960 ) stock hasn't...
Analysts Just Made A Notable Upgrade To Their Kindstar Globalgene Technology, Inc. (HKG:9960) Forecasts
Shareholders in Kindstar Globalgene Technology, Inc. ( HKG:9960 ) may be thrilled to learn that the analysts have just...
|9960||HK Healthcare||HK Market|
Return vs Industry: 9960 underperformed the Hong Kong Healthcare industry which returned -67.4% over the past year.
Return vs Market: 9960 underperformed the Hong Kong Market which returned -28.8% over the past year.
|9960 Average Weekly Movement||5.3%|
|Healthcare Industry Average Movement||6.7%|
|Market Average Movement||6.4%|
|10% most volatile stocks in HK Market||12.6%|
|10% least volatile stocks in HK Market||3.1%|
Stable Share Price: 9960 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 9960's weekly volatility (5%) has been stable over the past year.
About the Company
Kindstar Global (Beijing) Technology, Inc. provides medical esoteric testing services to hospitals in China. Its services include medical research, drug trial, and translational medicine research services for physicians, medical science and technology institutions, specialty and general hospitals, and pharmaceutical companies. The company’s lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research laboratories.
Kindstar Globalgene Technology, Inc. Fundamentals Summary
|9960 fundamental statistics|
Is 9960 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|9960 income statement (TTM)|
|Cost of Revenue||CN¥603.44m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.11|
|Net Profit Margin||9.53%|
How did 9960 perform over the long term?See historical performance and comparison